This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sunde, M. Articles by Death, A. K. Search for Related Content PubMed PubMed Citation Articles by Sunde, M. Articles by Death, A. K.

TC-1 Is a Novel Tumorigenic and Natively Disordered Protein Associated with Thyroid Cancer

¹ School of Molecular and Microbial Biosciences and ² Discipline of Medicine, University of Sydney, Australia; ³ Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, Australia; and ⁴ Heart Research Institute, Camperdown, Australia

A novel gene, thyroid cancer 1 (TC-1), was found recently to be overexpressed in thyroid cancer. TC-1 shows no homology to any of the known thyroid cancer-associated genes. We have produced stable transformants of normal thyroid cells that express the TC-1 gene, and these cells show increased proliferation rates and anchorage-independent growth in soft agar. Apoptosis rates also are decreased in the transformed cells. We also have expressed recombinant TC-1 protein and have undertaken a structural and functional characterization of the protein. The protein is monomeric and predominantly unstructured under conditions of physiologic salt and pH. This places it in the category of natively disordered proteins, a rapidly expanding group of proteins, many members of which play critical roles in cell regulation processes. We show that the protein can be phosphorylated by cyclic AMP-dependent protein kinase and protein kinase C, and the activity of both of these kinases is up-regulated when cells are stably transfected with TC-1. These results suggest that overexpression of TC-1 may be important in thyroid carcinogenesis.

This article has been cited by other articles:

				J. Kim, Y. Kim, H.-T. Kim, D. W. Kim, Y. Ha, J. Kim, C.-H. Kim, I. Lee, and K. Song TC1(C8orf4) Is a Novel Endothelial Inflammatory Regulator Enhancing NF-{kappa}B Activity J. Immunol., September 15, 2009; 183(6): 3996 - 4002. [Abstract] [Full Text] [PDF]

				J. Gsponer, M. E. Futschik, S. A. Teichmann, and M. M. Babu Tight Regulation of Unstructured Proteins: From Transcript Synthesis to Protein Degradation Science, November 28, 2008; 322(5906): 1365 - 1368. [Abstract] [Full Text] [PDF]

				Z. Q. Yang, K. L. Streicher, M. E. Ray, J. Abrams, and S. P. Ethier Multiple Interacting Oncogenes on the 8p11-p12 Amplicon in Human Breast Cancer Cancer Res., December 15, 2006; 66(24): 11632 - 11643. [Abstract] [Full Text] [PDF]

				B. Kim, H. Koo, S. Yang, S. Bang, Y. Jung, Y. Kim, J. Kim, J. Park, R. T. Moon, K. Song, et al. TC1(C8orf4) Correlates with Wnt/{beta}-Catenin Target Genes and Aggressive Biological Behavior in Gastric Cancer. Clin. Cancer Res., June 1, 2006; 12(11): 3541 - 3548. [Abstract] [Full Text] [PDF]

				Y. Jung, S. Bang, K. Choi, E. Kim, Y. Kim, J. Kim, J. Park, H. Koo, R. T. Moon, K. Song, et al. TC1 (C8orf4) Enhances the Wnt/{beta}-Catenin Pathway by Relieving Antagonistic Activity of Chibby Cancer Res., January 15, 2006; 66(2): 723 - 728. [Abstract] [Full Text] [PDF]